Theranostics Market Boom: Bridging the Gap Between Diagnosis and Therapeutics By 2031 | GE Healthcare, Jubilant Pharmova Limited (Jubilant Pharma Limited), Theragnostics Ltd., NuView Life Sciences, Lantheus Holdings, Inc., CapVest Limited (Curium Pharma)

The Global Theranostics Market reached USD 1.8 billion in 2022 and is expected to witness lucrative growth by reaching up to USD 4.2 billion by 2031. The global theranostics market is expected to exhibit a CAGR of 11.3% during the forecast period (2024-2031)

Theranostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/theranostics-market?an

Theranostics is a cutting-edge approach in medicine that combines diagnostics and therapeutics into a single treatment strategy. It involves the use of specific biomarkers or diagnostic tests to identify and monitor diseases, followed by personalized treatments based on the information gathered. Theranostics is particularly impactful in areas like cancer treatment, where it enables tailored therapies to target cancer cells more precisely, improving treatment efficacy and minimizing side effects. The goal is to provide individualized medicine for more effective and efficient care.

List of the Key Players in the Theranostics Market:

GE Healthcare, Jubilant Pharmova Limited (Jubilant Pharma Limited), Theragnostics Ltd., NuView Life Sciences, Lantheus Holdings, Inc., CapVest Limited (Curium Pharma), Clarity Pharmaceuticals, Cardinal Health, LLC, Advanced Accelerator Applications, and ITM Isotopen Technologien München AG among others.

Industry Development:

February 22, 2022: Theragnostics announced that NephroScan, its radiodiagnostic imaging drug designed to assist in evaluating renal parenchymal disorders in adult and pediatric patients, including term neonates, has received Marketing Approval from the US Food and Drug Administration (FDA).

February 10, 2022: Theragnostics, a company focused on developing radiopharmaceuticals for cancer imaging and treatment, revealed that its novel I-123 PARPi (THG-009) therapeutic agent has been granted an Innovation Passport by the UK Medicines and Healthcare Products Regulatory Agency (MHRA). The approval is for the treatment of primary and recurrent Glioblastoma Multiforme (GBM) under the MHRA's Innovative Licensing and Access Pathway (ILAP), aimed at accelerating the development and access to innovative medicines in the UK.

Growth Forecast Projected:

The Global Theranostics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Theranostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/theranostics-market

Segment Covered in the Theranostics Market:

By Application: Oncology, Neurological Disorder, Cardiovascular Disease and Others

By Radioisotopes: Technetium-99, Gallium-68, Lutetium (Lu) 177, Iodine-131, Zirconium-89 , Y-90 and Others

By End User: Hospitals, Cancer Research Institutes, Diagnostic Centers and Others

Regional Analysis for Theranostics Market:

The regional analysis of the Theranostics Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/theranostics-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Theranostics market?

➠ Who are the leading manufacturers in the global Theranostics industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Theranostics industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Theranostics market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/theranostics-market

Organoids Market - https://datamintelligence.com/research-report/organoids-market?an

Refurbished DNA Sequencing Platforms Market - https://datamintelligence.com/research-report/refurbished-dna-sequencing-platforms-market?an

miRNA Tools and Services Market - https://datamintelligence.com/research-report/mirna-tools-and-services-market?an

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.